Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Abd-Elsalam S, Esmail ES, Khalaf M, Abdo EF, Medhat MA, Abd El Ghafar MS, Ahmed OA, Soliman S et al (2020) Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study. Am J Trop Med Hyg 103:1635–1639
2. An MH, Kim MS, Kim BO, Kang SH, Kimn WJ, Park SK, Park HW, Yang W et al (2020) Treatment response to hydroxychloroquine and antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea. medRxiv. https://doi.org/10.1101/2020.07.04.20146548
3. Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M et al (2020) The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design. Ann Am Thorac Soc 17:879–891
4. Banerjee T, Anupurba S, Singh DK (2013) Poor compliance with the antibiotic policy in the intensive care unit (ICU) of a tertiary care hospital in India. J Infect Dev Ctries 15:7
5. Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G (2018) High prevalence and endemicity of multidrug resistant Acinetobacter spp. in intensive care unit of a Tertiary Care Hospital, Varanasi, India. J Pathog 2018:9129083
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献